TEVA logo

TEVA Total expenses

Annual total expenses:

$13.18B+$530.00M(+4.19%)
December 31, 2024

Summary

  • As of today (September 17, 2025), TEVA annual total expenses is $13.18 billion, with the most recent change of +$530.00 million (+4.19%) on December 31, 2024.
  • During the last 3 years, TEVA annual total expenses has risen by +$402.00 million (+3.15%).
  • TEVA annual total expenses is now -26.20% below its all-time high of $17.86 billion, reached on December 31, 2017.

Performance

TEVA Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Quarterly total expenses:

$4.01B+$357.78M(+9.80%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA quarterly total expenses is $4.01 billion, with the most recent change of +$357.78 million (+9.80%) on June 30, 2025.
  • Over the past year, TEVA quarterly total expenses has dropped by -$999.22 million (-19.96%).
  • TEVA quarterly total expenses is now -76.33% below its all-time high of $16.93 billion, reached on December 31, 2017.

Performance

TEVA Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

TEVA Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.2%-20.0%
3 y3 years+3.1%-0.3%
5 y5 years-7.0%+8.0%

TEVA Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+7.7%-23.6%+14.4%
5 y5-year-7.0%+7.7%-51.9%+14.4%
alltimeall time-26.2%>+9999.0%-76.3%>+9999.0%

TEVA Total expenses History

DateAnnualQuarterly
Jun 2025
-
$4.01B(+9.8%)
Mar 2025
-
$3.65B(-17.3%)
Dec 2024
$13.18B(+4.2%)
$4.41B(-7.6%)
Sep 2024
-
$4.78B(-4.6%)
Jun 2024
-
$5.01B(+26.1%)
Mar 2024
-
$3.97B(-1.1%)
Dec 2023
$12.65B(+3.4%)
$4.02B(+6.8%)
Sep 2023
-
$3.76B(-20.9%)
Jun 2023
-
$4.75B(+22.7%)
Mar 2023
-
$3.88B(-26.1%)
Dec 2022
$12.23B(-4.3%)
$5.24B(+49.6%)
Sep 2022
-
$3.50B(-12.8%)
Jun 2022
-
$4.02B(-12.6%)
Mar 2022
-
$4.60B(+8.0%)
Dec 2021
$12.78B(-6.0%)
$4.26B(+18.8%)
Sep 2021
-
$3.58B(-3.7%)
Jun 2021
-
$3.72B(-4.1%)
Mar 2021
-
$3.88B(-9.9%)
Dec 2020
$13.60B(-4.0%)
$4.30B(-48.3%)
Sep 2020
-
$8.33B(+124.5%)
Jun 2020
-
$3.71B(-12.3%)
Mar 2020
-
$4.23B(-2.7%)
Dec 2019
$14.17B(-8.0%)
$4.34B(-1.3%)
Sep 2019
-
$4.40B(-9.5%)
Jun 2019
-
$4.87B(+14.4%)
Mar 2019
-
$4.25B(-41.8%)
Dec 2018
$15.40B(-13.8%)
$7.30B(+54.2%)
Sep 2018
-
$4.74B(-2.9%)
Jun 2018
-
$4.88B(+23.6%)
Mar 2018
-
$3.94B(-76.7%)
Dec 2017
$17.86B(+3.2%)
$16.93B(+237.2%)
Sep 2017
-
$5.02B(-57.0%)
Jun 2017
-
$11.69B(+133.6%)
Mar 2017
-
$5.00B(-33.0%)
Dec 2016
$17.30B(+18.0%)
$7.46B(+44.9%)
Sep 2016
-
$5.15B(+7.7%)
Jun 2016
-
$4.78B(+14.6%)
Mar 2016
-
$4.17B(-4.7%)
Dec 2015
$14.66B(-7.1%)
$4.38B(-7.1%)
Sep 2015
-
$4.72B(+6.9%)
Jun 2015
-
$4.41B(-2.5%)
Mar 2015
-
$4.53B(+1.1%)
Dec 2014
$15.78B(-3.5%)
$4.47B(+7.0%)
Sep 2014
-
$4.18B(-2.7%)
Jun 2014
-
$4.30B(+0.9%)
Mar 2014
-
$4.26B(-17.6%)
Dec 2013
$16.35B(+1.3%)
$5.17B(+15.4%)
Sep 2013
-
$4.48B(-20.1%)
Jun 2013
-
$5.60B(+27.3%)
Mar 2013
-
$4.40B(-10.6%)
Dec 2012
$16.14B(+12.8%)
$4.93B(+1.6%)
Sep 2012
-
$4.85B(+20.6%)
Jun 2012
-
$4.02B(-0.9%)
Mar 2012
-
$4.06B(-17.9%)
Dec 2011
$14.30B(+20.8%)
$4.94B(+45.1%)
Sep 2011
-
$3.41B(-9.9%)
Jun 2011
-
$3.78B(+11.3%)
Mar 2011
-
$3.39B(-6.9%)
DateAnnualQuarterly
Dec 2010
$11.84B(+9.3%)
$3.65B(+15.5%)
Sep 2010
-
$3.16B(+4.1%)
Jun 2010
-
$3.03B(+3.2%)
Mar 2010
-
$2.94B(-16.1%)
Dec 2009
$10.83B(+10.4%)
$3.50B(+22.0%)
Sep 2009
-
$2.87B(+1.3%)
Jun 2009
-
$2.83B(+3.1%)
Mar 2009
-
$2.75B(-23.0%)
Dec 2008
$9.82B(+40.0%)
$3.57B(+60.5%)
Sep 2008
-
$2.22B(-0.4%)
Jun 2008
-
$2.23B(-7.4%)
Mar 2008
-
$2.41B(+16.0%)
Dec 2007
$7.01B(+11.1%)
$2.08B(+13.1%)
Sep 2007
-
$1.84B(-5.1%)
Jun 2007
-
$1.94B(+11.5%)
Mar 2007
-
$1.74B(-4.2%)
Dec 2006
$6.31B(+60.3%)
$1.81B(+8.6%)
Sep 2006
-
$1.67B(-0.5%)
Jun 2006
-
$1.67B(-37.7%)
Mar 2006
-
$2.69B(+153.1%)
Dec 2005
$3.94B(+8.7%)
$1.06B(+3.4%)
Sep 2005
-
$1.03B(+3.8%)
Jun 2005
-
$989.21M(-7.3%)
Mar 2005
-
$1.07B(+0.4%)
Dec 2004
$3.62B(+51.5%)
$1.06B(+7.0%)
Sep 2004
-
$994.11M(+6.6%)
Jun 2004
-
$932.68M(-36.9%)
Mar 2004
-
$1.48B(+92.2%)
Dec 2003
$2.39B(+19.9%)
$768.59M(+13.1%)
Sep 2003
-
$679.84M(+18.2%)
Jun 2003
-
$575.31M(-6.1%)
Mar 2003
-
$612.90M(-3.6%)
Dec 2002
$1.99B(+17.3%)
$635.96M(+21.1%)
Sep 2002
-
$525.19M(+18.1%)
Jun 2002
-
$444.54M(-3.3%)
Mar 2002
-
$459.50M(-5.8%)
Dec 2001
$1.70B(+23.7%)
$487.54M(+16.7%)
Sep 2001
-
$417.66M(-5.9%)
Jun 2001
-
$443.83M(+2.7%)
Mar 2001
-
$431.96M(>+9900.0%)
Dec 2000
$1.37B(+35.4%)
$0.00(-100.0%)
Dec 1999
$1.01B(+11.3%)
-
Dec 1998
$912.19M(-3.3%)
-
Sep 1998
-
$270.75M(+20.9%)
Jun 1998
-
$223.97M(-6.5%)
Mar 1998
-
$239.44M
Dec 1997
$943.10M(+14.4%)
-
Dec 1996
$824.50M(+16.6%)
-
Dec 1995
$707.10M(+13.2%)
-
Dec 1994
$624.80M(+50.9%)
-
Dec 1993
$414.00M(+21.2%)
-
Dec 1992
$341.60M(+24.2%)
-
Dec 1991
$275.00M(-4.7%)
-
Dec 1990
$288.70M(+21.9%)
-
Dec 1989
$236.90M(+25.6%)
-
Dec 1988
$188.60M(+56.8%)
-
Mar 1987
$120.30M(+51.7%)
-
Mar 1986
$79.30M
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual total expenses?
  • What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly total expenses?
  • What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?

What is Teva Pharmaceutical Industries Limited annual total expenses?

The current annual total expenses of TEVA is $13.18B

What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual total expenses is $17.86B

What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?

Over the past year, TEVA annual total expenses has changed by +$530.00M (+4.19%)

What is Teva Pharmaceutical Industries Limited quarterly total expenses?

The current quarterly total expenses of TEVA is $4.01B

What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly total expenses is $16.93B

What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?

Over the past year, TEVA quarterly total expenses has changed by -$999.22M (-19.96%)
On this page